Valor Named to Fortune Best Workplaces List
Fortune Media and Great Place To Work Name Valor to 2024 Fortune Best Small Workplaces™
"We are incredibly honored to be recognized by Fortune as one of the best companies to work for in the country. To learn that 1.3 million responses were received from companies nationwide and that Valor rose to the top, is truly remarkable," said
Great Place To Work selected the Fortune Best Small Workplaces List by surveying companies employing 8.2 million people in the
"Some of the strongest work cultures we measure every year come from companies with relatively small headcounts," says
Valor prioritizes providing their employees with many benefits, including 100% of health insurance premiums paid for all employees, paid maternity and paternity leave, employer-sponsored Life/AD&D, 401k retirement plan, paid holidays and generous PTO. Benefits such as these have been largely impactful in Valor being named to several award lists in 2024, including Best Place for Working Parents®, Fort Worth Inc.'s Best Companies to Work For, Inc. 5000, Inc. Regionals Southwest, The Best and Brightest Programs Best and Brightest in the Nation, Inc. Best Workplaces and Great Place To Work and Fortune Magazine Best Workplaces in Texas.
Headquartered in
About Valor:
Valor is an oil and gas asset management services provider that serves mineral rights owners and oil and gas operators and investors. We place the client first, providing flexible solutions and leveraging our team of experts to maintain the security, clarity and optimization of privately owned assets. Valor is headquartered in
Media Contact:
Hannah
817-370-0612
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/valor-named-to-fortune-best-workplaces-list-302264897.html
SOURCE Valor
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GIM Raises US$20 Million Series A as Agentic Investing Enters Live Execution
- Roche receives CE Mark for blood test to identify tuberculosis infection
- Groundbreaking Achievement: Study of Ensartinib as Postoperative Adjuvant Therapy Published in The New England Journal of Medicine
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share